CD274 and neoplasm: Importantly for the activity of anti-tumor T cells, the combination of TGFβ blockade and anti-PDL1 has been shown to decrease the activity of fibroblasts and the density of ECM relieving the exclusion of T cells from malignant cells (46, 47).